In Brief
Using genetic ablation of Smad2/3 effectors downstream of Nodal signaling in mouse embryonic stem cells, Senft et al. show a requirement for Smad2/3 signaling to maintain embryonic/extraembryonic cell identities during lineage priming before mesoderm and endoderm cell fate allocation and to balance Nodal/ Bmp signaling during ectoderm differentiation.
INTRODUCTION
The strict segregation of embryonic and extra-embryonic tissues constitutes the earliest cell fate decision in the pre-implantation mammalian embryo. Later, during gastrulation through coordinated patterning by Nodal and Bmp signaling, pluripotent epiblast cells are induced to form the three primary germ layers: mesoderm, definitive endoderm (DE), and ectoderm (Robertson, 2014) . However, studies demonstrate that epiblast cells acquire competence to differentiate in response to inductive signaling cues at earlier stages (Smith, 2017) . This cellular transition, designated as lineage priming or epiblast maturation and characterized in cultured epiblast-like cells (EpiLCs) (Buecker et al., 2014; Hayashi et al., 2011) , is associated with genome-wide reorganization of active enhancers, resulting in decreased expression of naive pluripotency genes, activation of primed and early differentiation genes, and importantly, stable repression of extra-embryonic gene expression (Morgani et al., 2017; Murakami et al., 2016) . However, relatively little is known about the underlying molecular mechanisms driving these cellular events.
Our early work showed that Nodal, a member of the transforming growth factor b (TGF-b) superfamily of secreted growth factors, is required for axis patterning in the early post-implantation stage embryo (Brennan et al., 2001 ). Loss-of-function embryos arrest before gastrulation, fail to form mesoderm, prematurely lose expression of pluripotency markers, and precociously activate neuroectoderm markers (Brennan et al., 2001; Camus et al., 2006; Mesnard et al., 2006) . Nodal receptors activate the closely related downstream intracellular effectors Smad2 and Smad3 (Smad2/3) that translocate into the nucleus to regulate target gene expression (Massagué , 2012) . Smad2/3 share >90% amino acid identity and display partially overlapping expression patterns in the early embryo (Dunn et al., 2004; Waldrip et al., 1998) . However, loss-of-function mutants display strikingly different phenotypes. Animals lacking Smad3 are adult viable (Datto et al., 1999) . In contrast, Smad2 mutant embryos fail to acquire anterior-posterior patterning and arrest shortly after implantation (Waldrip et al., 1998) . Instead, because of loss of Smad2 in the extra-embryonic primitive endoderm (where Smad3 is not expressed), the epiblast defaults exclusively to an extra-embryonic mesodermal fate (Dunn et al., 2004; Waldrip et al., 1998) . Smad3 expression from the Smad2 locus can rescue the lethal phenotype (Dunn et al., 2005) . Moreover, Smad2/3 clearly function in a dose-dependent manner (Vincent et al., 2003) . Thus, double-mutant embryos lacking both Smad2/3 abruptly arrest shortly after implantation and are severely disorganized (Dunn et al., 2004) .
Previous efforts aimed at dissecting partially overlapping Smad2/3 functional contributions have been hampered by this early lethality. Here we exploited embryonic stem cells (ESCs) lacking both Smad2/3, in combination with directed in vitro differentiation protocols, to gain insight into the underlying defects. We observe that Smad2/3 doublemutant ESCs fail to undergo lineage priming or correct cell fate allocation and ectopically activate extra-embryonic genes. This priming defect was associated with inappropriate activation of Oct4-bound distal regulatory sites and enhanced Bmp target gene expression. Collectively, the present results demonstrate that combinatorial Smad2/3 activities are required to maintain embryonic identity in the early epiblast during lineage priming. Figure S1A ).
RESULTS

Smad2
Correctly targeted clones were identified by Southern blot analysis, and loss of Smad3 protein expression was confirmed by western blotting (Figures S1B and S1C). WT, Smad2 KO, Smad3 KO, and Smad2/3 DKO ESCs cultured under 2i + LIF (2iL) or serum + LIF (SL) conditions were morphologically indistinguishable ( Figure S1D ). Smad2/3 DKO ESCs efficiently formed colonies and displayed robust Oct4 and Nanog expression levels ( Figures 1A, S1D , and S1E).
To examine gene expression changes, we carried out transcriptional profiling experiments using microarrays. We identified 422 genes with significantly changed expression levels (209 down and 213 up) in Smad2/3 DKO ESCs cultured under SL conditions compared to WT ESCs ( Figure 1B ; Table S1 ). Several Nodal targets (Lefty1/2 and Pitx2) were downregulated, while Bmp target genes (Id1/2/3) were upregulated. Genes normally confined to trophectoderm derivatives (Tle3, Plac1, Pparg, and Prl2c3) and extra-embryonic primitive endoderm (Pdgfra and Sox7) were upregulated in Smad2/3 DKO ESCs. A subset of differentially expressed genes was also significantly altered in either Smad2 KO or Smad3 KO ESCs (33% and 12%, respectively) ( Figure 1B ). Smad2, but not Smad3, KO ESCs display upregulated extra-embryonic gene expression. There was no evidence for altered expression of pluripotency markers (Table S1 ).
Loss of Smad2/3 Results in Activation of ExtraEmbryonic and Bmp Target Gene Expression upon Exit from the Undifferentiated State To test whether these transcriptional changes potentially influence exit from the naive state, we induced differentiation by plating ESCs (SL) at low density in the absence of LIF and performed alkaline phosphatase (AP) staining to identify naive ESCs. Similar to WT or single-KO ESCs, Smad2/3 DKO ESCs gave rise to AP-negative colonies ( Figure 1C ). As for Figure 1 . Smad2/3 Repress Expression of Extra-Embryonic and Naive Pluripotency Genes during Lineage Priming (A) WT, Smad2 KO, Smad3 KO, or Smad2/3 DKO ESCs (2iL) were stained for Oct4 and Nanog and counterstained with DAPI. (B) Venn diagrams showing significant changes in gene expression shared by Smad2 KO, Smad3 KO, and Smad2/3 DKO ESCs, relative to WT ESCs, as determined by microarray profiling (n = 3 or 4). Genes uniquely differentially expressed by Smad2 KO or Smad3 KO ESCs were excluded from this analysis. A summary of deregulated genes is presented in Table S1 . (C) Pie charts of alkaline phosphatase (AP)-stained WT, Smad2 KO, Smad3 KO, or Smad2/3 DKO ESCs cultured for 5 days in the presence or absence of LIF (n = 3), corresponding to pluripotent, differentiated, or mixed colonies. See also Figure S1F . (D) Scatterplot showing significantly (p < 0.05, Benjamini-Hochberg adjusted) differentially expressed genes in Smad2/3 DKO EpiLCs compared to WT by RNA-seq (n = 3). The cutoff was set to >1.5-fold change. Differentially expressed genes near Smad2/3 ChIP-seq peaks in day 3 EBs (%50 kb of its transcriptional start site [TSS] ) are indicated in yellow. The pie chart indicates the proportion of differentially expressed genes also showing Smad2/3 ChIP-seq peaks (%50 kb of TSS). (E) Heatmap showing relative expression levels of pluripotency marker genes in Smad2/3 DKO ESCs, EpiLCs, and day 3 EBs compared to WT controls (n = 3 or 4). Profiles of Smad2 KO and Smad3 KO day 3 EBs are shown on the right. BMP4-treated WT ESCs that similarly exhibit a bias toward extraembryonic gene expression, Smad2/3 DKO and to a lesser extent Smad2 KO ESC colonies displayed a distinctive, more flattened, epithelial morphology (Hayashi et al., 2010) (Figure S1F ).
To further explore exit from the naive state, we compared gene expression profiles of WT and Smad2/3 DKO EpiLCs using RNA sequencing (RNA-seq). As expected, WT ESCs (2iL) induced to form EpiLCs by activin A and Fgf2 treatment adopted a flattened cell morphology. The appearance of Smad2/3 DKO EpiLCs closely resembled WT ( Figure S1G ). RNA-seq analysis identified 2,098 genes with significantly changed expression in Smad2/3 DKO compared to WT EpiLCs (1,100 down and 998 up) (Figure 1D ; Table S2 ). We found that expression levels of Nodaldependent genes (e.g., Lefty1/2 and Pitx2) and early mesoderm markers (e.g., T and Fgf8) were downregulated in Smad2/3 DKO EpiLCs. However, Bmp targets (e.g., Id1/2/3/4) and extra-embryonic ectoderm (e.g., Fgfr2 and Tfap2c), trophectoderm (e.g., Gata2 and Gata3), and visceral endoderm (VE) (e.g., H19 and Sparc) marker genes were activated.
Next, we compared the list of differentially expressed genes with published Smad2/3 chromatin immunoprecipitation sequencing (ChIP-seq) datasets . We found that 18% of differentially expressed genes in Smad2/3 DKO EpiLCs were occupied by Smad2/3 in differentiated embryoid bodies (EBs), in contrast to only 3% in ESCs (Table S2 ). Smad2/3-occupied differentially expressed genes included both Nodal and Bmp targets. Except for Fgfr2 and Tfap2c (encoding Ap2g) none of the ectopically activated extra-embryonic genes were found to be Smad2/3 occupied, which implicates an indirect regulatory mechanism, assuming Smad2/3 occupancy is similar between EpiLCs and EBs.
Combinatorial Smad2/3 Activities Control PluripotencyAssociated Gene Expression during Lineage Priming Smad2/3 DKO EpiLCs display enhanced expression of naive pluripotency markers (e.g., Klf2 and Rex1) characteristic of the blastocyst inner cell mass, together with decreased expression of primed pluripotency markers (e.g., Fgf5 and Oct6) ( Figure 1E ). Reduced Oct6 expression was confirmed by immunofluorescence staining experiments ( Figure S1G ). In contrast, expression of the epiblast marker Otx2 was unchanged (Figures 1E and S1G) . To further examine gene expression changes during differentiation, Smad2/3 DKO ESCs were induced to form EBs and transcriptional profiles were analyzed using microarrays. As shown in Figure 1E , Smad2/3 DKO EBs display striking downregulation of primed pluripotency markers and upregulated expression of naive pluripotency genes. In addition, when we analyzed single-KO EBs, we found that Smad2 KO EBs, but not Smad3 KO EBs, resembled Smad2/3 DKO EBs. Consistent with this, EpiLCs express Smad2 at roughly 5-fold higher levels in comparison with Smad3. Thus, Smad2 activity is predominantly responsible for governing the gain of primed and/or differentiated identity during lineage priming.
Smad2/3 Influence Chromatin Accessibility during the ESC-to-EpiLC Transition
The preceding results demonstrate that Smad2/3 activities regulate pluripotency-associated gene expression. However, we detected a relatively low degree of overlap between Smad2/3-dependent transcripts and nearby sites of Smad2/3 binding using published Smad2/3 ChIP-seq datasets from day 3 EBs . These experimental approaches provided only a limited view of the Smad2/3 regulatory network. Global changes in the activities of distal regulatory elements, such as enhancers, during acquisition of the primed state have been previously documented (Buecker et al., 2014; Factor et al., 2014) . Therefore, we decided to evaluate possible changes affecting the distal regulatory element landscape in Smad2/3 DKO EpiLCs using the assay for transposase accessible chromatin (ATAC)-seq.
We identified 4,274 regulatory elements that were differentially accessible in Smad2/3 DKO compared to WT EpiLCs (3,234 decreased and 1,040 increased) ( Figure 2A ; Table S3 ). To explore the possibility that Smad2/3-dependent regulatory elements potentially influence the transition to the primed state, we identified sites where chromatin accessibility is changed during the ESC-to-EpiLC transition by comparing EpiLC ATAC-seq data with our published WT ESC ATAC-seq dataset (Simon et al., 2017) . Most (90%) Smad2/3-dependent sites undergo changes in chromatin accessibility during the ESC-to-EpiLC transition ( Figure 2B ). Furthermore, many of these were located more than 5 kb from transcriptional start sites ( Figure 2C ) and displayed an enrichment for markers of distal regulatory elements, including p300, H3K27ac, and H3K4me1 ( Figure 2D ). These observations suggest that combinatorial Smad2/3 activities influence the global reconfiguration of the chromatin landscape during lineage priming.
Changes in chromatin accessibility at distal regulatory elements in Smad2/3 DKO EpiLCs potentially influence expression of nearby genes. To test this possibility, we compared ATAC-seq and transcriptional profiles. We found that sites with decreased accessibility were associated with reduced expression of nearby genes ( Figure 2E ). For example, Lefty1/2 and Pitx2 display decreased chromatin accessibility at nearby enhancer regions normally occupied by Smad2/3 during differentiation (Figures 2F, 2G, and S2A) . In contrast, sites that displayed increased chromatin accessibility were associated with increased expression levels ( Figure 2E ); however, unlike sites showing decreased accessibility, these loci tended to have lower levels of Smad2/3 binding ( Figure 2G ). Sites of increased accessibility are associated with increased Smad1 occupancy in BMP4-treated ESCs (Figure 2G ). Collectively, these results demonstrate that Smad2/3 act to promote full access to distal regulatory elements governing gene expression changes necessary for cells to transition to the primed state.
Oct4 and Otx2 Occupy Smad2/3-Dependent Distal Regulatory Elements Studies demonstrate that Oct4 binding switches from naive enhancers to primed enhancers at pluripotency genes coincident with occupancy by so-called mediators of the primed state, such as Otx2, during the ESC-to-EpiLC transition (Buecker et al., 2014) . Here we observe in EpiLCs an enrichment of Oct4 and Otx2 ChIP-seq signals at Smad2/3-dependent sites that display decreased chromatin accessibility (Figures 2F and 2G) . Motif enrichment analysis confirmed these sites are highly enriched for Oct4 and Otx2 binding motifs and those recognized by other priming factors, e.g., Oct6 and Foxd3 (Figure 2H) . Fgf5, Oct6, and Foxa2, genes characteristic of the primed state, display decreased accessibility (Figures 2F and S2B) . In contrast, in the absence of Smad2/3, Klf2, an Oct4/ Otx2-occupied gene that characterizes the naive state, shows increased accessibility at a neighboring distal regulatory element and increased expression levels ( Figure 2F ). These genomic regions were also enriched for naive, extra-embryonic, and neural transcription factor binding motifs ( Figure 2H ). However, accessibility near early differentiation and extraembryonic marker genes appeared to be largely unaffected ( Figures S2C and S2D ). These observations strengthen the argument that cooperative binding by different transcription factors is required during lineage priming and demonstrate that Smad2/3, together with the pioneer factor Oct4 (Mullen et al., 2011; Ruetz et al., 2017) , targets distal regulatory elements controlling the transition from the naive to the primed state.
Loss of Smad2/3 Disrupts Cell Fate Allocation during ESC Differentiation
To investigate downstream consequences resulting from this priming defect, we re-examined the Smad2/3 DKO EB microarray profiles. We identified 3,104 genes showing significantly changed expression levels in Smad2/3 DKO compared to WT Table S3 . (B and C) Pie charts indicating (B) distributions of differential accessible sites in Smad2/3 DKO EpiLCs compared to WT overlapping with regulatory elements gained or lost during the ESC-toEpiLC transition or (C) the distance to known TSS as defined by Genomic Regions Enrichment of Annotations Tool (GREAT). (D) Heatmap read density plots of p300, H3K27ac, and H3K4me1 ChIP-seq signal at regulatory elements with differential accessibility in Smad2/3 DKO EpiLCs (ranked as in A). (E) Heatmap depicting the log2 fold change (log2FC) in gene expression in Smad2/3 DKO EpiLCs relative to WT EpiLCs as determined by RNA-seq. Genes nearest regulatory elements with differential accessibility in Smad2/3 DKO EpiLCs are shown. (F) Genome browser snapshots of RNA-seq and ATAC-seq tracks in Smad2/3 DKO and WT EpiLCs at selected genomic loci. ATAC-seq of WT ESCs, ChIP-seq tracks of Smad2/3 occupancy in ESCs and day 3 EBs, and Oct4 and Otx2 occupancy in EpiLCs are also shown. (G) Heatmap read density plots of WT Smad2/3, Smad1, Oct4, and Otx2 ChIP-seq signal in the indicated cell types at regulatory elements with differential accessibility in Smad2/3 DKO EpiLCs (ranked as in A). ESCs were treated with 10 ng/mL BMP4 for Smad1 ChIP-seq. (H) Motif enrichment analysis of regulatory elements with differential chromatin accessibility in Smad2/3 DKO EpiLCs. Motifs for transcription factors associated with primed or naive, extraembryonic, and neural cell states were significantly enriched. day 3 EBs (1,487 down and 1,617 up) ( Figure S3A ). Expression of the top 20 genes normally activated during differentiation was dramatically reduced in Smad2/3 DKO EBs ( Figure 3A) . Expression of several mesodermal (Wnt3, T, Fgf8, Mixl1, Sp8, Eomes, Mesp1, and Lhx1) and DE lineage marker genes (Foxa2, Sox17, Cxcr4, and Gata6), including a subset known to be direct targets of Smad2/3 in EBs , were significantly downregulated (Table S1 ). Profiling at an earlier point revealed that expression of a subset of differentiation genes (e.g., T, Cdx2, Wnt8a, and Sp5) was initially induced in Smad2/3 DKO day 2 EBs but failed to be maintained. These transcriptional changes were validated for selected genes by immunofluorescent staining ( Figure S3B ). Experiments analyzing single-KO EBs demonstrate that both Smad2/3 contribute to expression changes ( Figures S3A and S3C) . When differentially expressed genes in Smad2/3 DKO day 3 EBs were assessed for their relative expression changes in Smad2/3 DKO EpiLCs and ESCs, we found that Smad2/3 is essential for correct gene expression patterns during differentiation at early stages as cells enter the primed state ( Figure S3D ).
Primordial germ cells (PGCs) are specified in the early epiblast in response to Bmp signaling from the extra-embryonic ectoderm. To test whether PGC specification is affected by loss of Smad2/3, we exploited PGC-like cell (PGCLC) differentiation protocols (Hayashi and Saitou, 2013) . AP2g/Oct4 co-expression identifies PGCs in the early embryo. In WT cultures, Oct4/AP2g double-positive cells were readily apparent at day 2 and abundant numbers were present at day 4, but by contrast, day 2 and 4 Smad2/3 DKO cultures contained predominantly Oct4 and AP2g single-positive cells (Figure 3B ), allowing us to conclude that their ability to acquire PGC-like fates is also compromised.
Smad2/3 Governs the Balance of Nodal/Bmp Signaling during Ectoderm Specification
To evaluate whether ectodermal cell fate decisions are also Smad2/3 dependent, we exploited culture protocols that promote neuroectodermal precursor cell (NPC) formation. Tuj1+ staining identified a subpopulation of bona fide elongated neural cells in day 7 Smad2/3 DKO cultures ( Figure 3C ). However, as for BMP4-treated WT NPCs (Malaguti et al., 2013) , from day 3 onward, most cells displayed a flattened epithelial, surface-ectoderm-like morphology ( Figure 3D ). At day 5, a high proportion of WT cells expresses the early neural marker Sox1. BMP4 treatment normally represses Sox1 expression in WT cultures ( Figures 3E and S3E) . In Smad2/3 DKO NPCs, the proportion of Sox1+ cells is markedly reduced, but not eliminated. Similarly, expression of the neural marker Six3 was absent from BMP4-treated NPCs and significantly reduced in Smad2/3 DKO NPCs ( Figure S3E ). Moreover, Smad2/3 DKO NPCs exhibited ectopic expression of AP2g and the epithelial marker Krt18, normally present only in BMP4-treated WT cultures ( Figures 3E and S3E) . Thus, neural fate appears to be induced in a subpopulation of Smad2/3 DKO cells. However, terminal differentiation of neuroectodermal cells is compromised, possibly due to increased Bmp signaling. Thus, as reported for Alk4/5/7 inhibitor-treated ectoderm explants ), here we found that combinatorial Smad2/3 activities are required for fine-tuning the balance of neural versus epidermal cell fates.
Ectopic Activation of Extra-Embryonic Gene Expression in Smad2/3-Deficient EBs Expression of Bmp target genes (Id1-Id4) was upregulated in Smad2/3 DKO compared to WT ESCs, EpiLCs, and day 3 EBs, consistent with increased levels of Bmp signaling activities ( Figure 4A ). To examine this possibility, we differentiated Smad2/3 DKO EBs in the presence and absence of the Bmp type 1 receptor inhibitor LDN-193189 . In contrast to WT EBs, in which Bmp receptor inhibition markedly reduced p-S1/5/8 levels, we found that Smad2/3 DKO EBs are refractory to LDN-193189 treatment, with levels of p-S1/5/8 and Id1 remaining un- Table S1 . changed ( Figure 4B ). Next, we evaluated possibly elevated Bmp signaling in embryonic day 5.5 (E5.5) double-mutant embryos. In WT embryos p-S1/5/8 staining is restricted to the proximal VE, while in mutant embryos ectopic nuclear p-S1/5/ 8 staining is present throughout the VE ( Figure 4C ). Consistent with this, in double-mutant embryos VE specification is disrupted, as seen by loss of both Eomes and Otx2 expression ( Figure 4D ).
Bmp signaling has been shown to activate extra-embryonic gene expression (Hayashi et al., 2010) . Similarly, in Smad2/3 DKO day 3 EBs, a subset of trophectoderm-derived, extra-embryonic tissue-expressed genes (e.g., Plac1, Rhox6, Rhox9, and Ascl2) and VE genes (e.g., H19) shows strongly upregulated expression ( Figure 4E ). However, expression of other essential extra-embryonic genes (e.g., Elf5) was unaffected. Thus, we conclude that Smad2/3-deficient cells are not simply defaulting to defined extra-embryonic fates.
Embryonic and extra-embryonic tissues in the early postimplantation mouse embryo show distinct patterns of DNA methylation . In addition, in the epiblast, DNA methylation gradually increases, coincident with the exit from naive pluripotency (Auclair et al., 2014; Kalkan et al., 2017) . Reduced DNA methylation has been shown to cause disturbances, affecting the maintenance of embryonic and/or extraembryonic cell identity and ESC differentiation (Jackson et al., 2004; Ng et al., 2008; Sakaue et al., 2010) . Reduced Bmp signaling in Smad1/5 DKO ESCs results in increased Dnmt3b levels, enhanced DNA methylation, and more efficient embryonic differentiation (Gomes Fernandes et al., 2016) . Consistent with enhanced Bmp signaling, we found that Smad2/3 DKO day 3 EBs display decreased Dnmt3b expression and increased expression of genes associated with DNA demethylation (Tet2 and Gadd45b) ( Figure 4A ). Extra-embryonically expressed imprinted genes (e.g., Rhox5, H19, Igf2, Ascl2, and Peg10), whose differential expression is controlled by DNA methylation, were also upregulated (Table S1 ). It is tempting to speculate that ectopic extra-embryonic gene expression in Smad2/3-deficient EBs reflects enhanced Bmp signaling, together with changes affecting the patterns of DNA methylation.
DISCUSSION
We reported many years ago that double Smad2/3 homozygous mutant embryos abruptly arrest at early post-implantation stages (Dunn et al., 2004) . However, it has proved difficult to characterize the underlying molecular defects responsible for this early lethality. Here we generated double Smad2/3 homozygous null ESCs and investigated their differentiation capabilities. Our genome-wide transcriptional profiling experiments demonstrate that Smad2/3 activities in early epiblast cells are required to promote the transition from naive pluripotency to lineage priming and the onset of cell fate allocation.
Our ATAC-seq analysis of Smad2/3 DKO EpiLCs revealed changes in chromatin accessibility at distal regulatory elements occupied by the pioneer transcription factor Oct4 and its interaction partner Otx2 (Buecker et al., 2014; King and Klose, 2017) . These changes were closely associated with expression changes at nearby genes. Oct4 interactions with Smad2/3 were previously described in naive and primed cells (Mullen et al., 2011; Sun et al., 2014) . It has been proposed that Smad2/3 facilitates accessibility at Oct4-dependent enhancer sites through interactions with chromatin modifiers and remodelers (Funa et al., 2015; Ruetz et al., 2017) . The present experiments support the idea that Smad2/3/Oct4/Otx2 transcription complexes are required to mediate cellular transitions from naive to primed and primed to differentiated states. It will be interesting to learn more about associations with additional cofactors having an impact on chromatin structure and transcriptional output at specific target loci.
Early epiblast cells normally undergo lineage priming in the context of tightly balanced reciprocal Nodal/Smad2 and Bmp/Smad1 signaling cues between the embryonic and the extra-embryonic tissues (Ben-Haim et al., 2006; Yamamoto et al., 2009) . The present experiments demonstrate that Smad2/3 inactivation results in upregulated Bmp target and extra-embryonic gene expression. Similarly, in Smad2/3 doublemutant embryos, we find ectopic Bmp signaling throughout the distal VE. Studies also suggest that Bmp signaling promotes DNA hypo-methylation in ESCs (Gomes Fernandes et al., 2016) . It is tempting to speculate that Smad2/3 activities normally antagonize Bmp signaling and promote DNA methylation selectively in the early epiblast to maintain its developmental potential and prevent contributions to the extra-embryonic cell lineages.
Smad2/3 DKO embryos are more severely disturbed and die earlier in comparison with Nodal KO embryos (Brennan et al., 2001; Dunn et al., 2004 In contrast, we found that Smad2/3 DKO ESCs induced to differentiate display reduced neural and enhanced surface ectoderm-like and extra-embryonic gene expression. The simplest explanation is that in the absence of Nodal, closely related Smad2/3-dependent TGF-b family members like Gdf1 and Gdf3 partially compensate (Andersson et al., 2007) . Consistent with this possibility, Nodal-deficient blastocysts have the ability to activate the Smad2/3-dependent Nodal anterior streak enhancer (Granier et al., 2011) . Moreover, unlike Smad2/3 DKO ESCs, Nodal KO ESCs efficiently contribute to embryonic cell lineages (Conlon et al., 1991) . Widespread tissue defects observed in Smad2/3 DKO embryos are also considerably more severe compared with those reported for mutant embryos lacking Fgf5, Oct6, or Otx2 (Ang et al., 1996; Bermingham et al., 1996; Hé bert et al., 1994) . Thus, it appears that the profound developmental block in Smad2/3 DKO embryos reflects not only defective lineage priming and embryonic cell fate allocation but also additional disturbances caused by de-repressed Bmp target gene and ectopic extra-embryonic gene expression.
Overall, our experiments demonstrate that combinatorial Smad2/3 functional activities collaboratively maintain distinct embryonic and/or extra-embryonic cell identities and strictly divergent lineage-specific transcriptional programs in the early mouse embryo.
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Detailed methods are provided in the online version of this paper and include the following: 
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ESC culture
All ESC lines used were XY and grown in feeder-free conditions on 0.1% gelatin-coated dishes at 6% CO 2 at 37 C. ESCs were cultured in DMEM (GIBCO, Cat#11960-085) supplemented with 15% FBS (GIBCO Cat#10500-062, Lot: 07Q3446K), 1% PEN/ STREP, 1% glutamine, 1% NEAA, 1mM sodium pyruvate, 100 mM b-mercaptoethanol and 1000 U/ml LIF (SL). Alternatively, ESCs were cultured in serum-free media containing N2B27 (NDiffâ227, Cat#Y40002) supplemented with 1 mM PD0325091 and 3 mM CHIR99021 and 1000 U/ml LIF (2iL).
METHOD DETAILS
Generation of knockout lines Smad3 KO and Smad2/3 DKO ESC lines Two sets of four sgRNAs flanking exon 1 of murine Smad3 were designed using the Zhang lab CRISPR design tool (Hsu et al., 2013) taking care to avoid T-rich 3 0 ends and to keep off-sets between nickase-sgRNAs < 10 bp. The PAM sequence was removed and BbsI sites engineered at the ends. After cloning into pSpCas9n(BB)-2A-GFP (PX461) (Ran et al., 2013) constructs were transfected into Stbl3 cells. Efficiency of sgRNA plasmids was confirmed by high resolution melt analysis. A maximum of 5 mg pooled isolated non-linearized plasmid DNAs (QIAGEN Maxi Prep kit, Cat#12663) was transfected into 1 3 10 6 ESCs (either 129/Sv//Ev CCE WT (Robertson et al., 1986) or Smad2 tm1Rob/tm1Rob (Tremblay et al., 2000) ) using the Neonâ transfection system (Thermo Fisher Scientific, Cat#MPK5000) followed by low-density plating. Deletion of exon 1 was screened for by Southern blotting using a XbaI digest and a probe 3 0 to the deletion (for sequences see Table S4 ). Loss of Smad3 protein was confirmed by western blotting using specific antibodies (see Key Resources Table) .
Conventional Smad3
À/À control lines
To generate Smad3 À/À ESCs, blastocysts were obtained from Smad3 tm1Xfw/+ females mated to Smad3 tm1Xfw/+ males. ESC lines were isolated in 2iL as previously described (Ying et al., 2008) . Homozygous lines were identified by PCR using the genotyping primers listed in Table S4 .
EpiLC induction
EpiLCs were induced from ESCs (2iL) as previously described (Hayashi et al., 2011) . In brief, 2.33 3 10 5 cells were washed and resuspended in N2B27 medium (Takara, Cat#Y40002) supplemented with 12ng/ml Fgf2, 20ng/ml Activin A and 1% KSR (GIBCO, Cat#10828, Lot:1508151) and grown on fibronectin-coated (5 mg/cm 2 ) 6cm dishes. Medium was exchanged daily and cells grown for 48h to form EpiLCs.
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Sequencing data from Smad2/3 ChIP-seq in mouse ESCs and embryoid bodies treated with Activin A or SB-431242 ) GSE70486
Sequencing data from ATAC-seq in mouse ESCs and in vitro differentiated definitive endoderm (Simon et al., 2017 ) GSE94250
Sequencing data from Smad1 ChIP-seq in mouse ESCs treated with BMP4 ) GSE70581 et al., 2017 . Enrichment of transcription factor motifs in differentially accessible ATAC-seq peaks was performed using the Analysis of Motif Enrichment (AME) feature in the MEME suite (McLeay and Bailey, 2010 ) with a background control of unaffected ATAC-seq peaks.
DATA AND SOFTWARE AVAILABILITY
The accession number for the data reported in this paper is GEO: GSE110164 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi? acc=GSE110164).
